Major Depressive Disorder

Showing NaN - NaN of 62

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
  • Major Depressive Disorder
  • Arcadia, California
  • +49 more
Feb 2, 2016

Treatment-Resistant Depression Registry

Completed
  • Major Depressive Disorder
    • Tucson, Arizona
    • +54 more
    Dec 22, 2015

    MDD Trial in United States (ADT, OPC-34712)

    Completed
    • Major Depressive Disorder
    • Arcadia, California
    • +31 more
    Oct 6, 2015

    MDD Trial in United States (OPC-34712, Placebo, ADT)

    Completed
    • Major Depressive Disorder
    • Birmingham, Alabama
    • +42 more
    Sep 30, 2015

    MDD Trial in United States (tasimelteon, )

    Completed
    • Major Depressive Disorder
    • Garden Grove, California
    • +39 more
    Jun 1, 2015

    MDD Trial in Portland (Interactive voice messaging or Interactive voice messaging + psycho ed materials)

    Completed
    • Major Depressive Disorder
    • Interactive voice messaging or Interactive voice messaging + psycho ed materials
    • Portland, Oregon
      Kaiser Permanente Center for Health Research
    Mar 12, 2015

    MDD Trial in Worldwide (Desvenlafaxine succinate sustained release 50 mg, Desvenlafaxine succinate sustained release 25 mg,

    Completed
    • Major Depressive Disorder
    • Desvenlafaxine succinate sustained release 50 mg
    • +2 more
    • Beverly Hills, California
    • +88 more
    Nov 6, 2014

    MDD Trial in United States (Vilazodone, Placebo to citalopram, Placebo to vilazodone)

    Completed
    • Major Depressive Disorder
    • Birmingham, Alabama
    • +53 more
    Aug 6, 2014

    MDD Trial in United States (Placebo, Escitalopram, JNJ-18038683)

    Completed
    • Major Depressive Disorder
    • Placebo
    • +2 more
    • Little Rock, Arkansas
    • +25 more
    Aug 1, 2014

    MDD, Depression Trial in India, United States (TC-5214, Placebo)

    Completed
    • Major Depressive Disorder
    • Depression
    • Tuscaloosa, Alabama
    • +50 more
    Mar 14, 2014

    MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)

    Completed
    • Major Depressive Disorder
    • +2 more
    • Birmingham, Alabama
    • +93 more
    Mar 14, 2014

    MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)

    Completed
    • Major Depressive Disorder
    • Depression
    • Birmingham, Alabama
    • +98 more
    Mar 14, 2014

    MDD Trial in Portland (Cognitive Behavioral Therapy (CBT), Active control)

    Completed
    • Major Depressive Disorder
    • Cognitive Behavioral Therapy (CBT)
    • Active control
    • Portland, Oregon
      Kaiser Permanente Center for Health Research
    Jan 30, 2014

    MDD Trial in United States (desvenlafaxine succinate sustained-release 50 mg/day, desvenlafaxine succinate sustained-release 100

    Completed
    • Major Depressive Disorder
    • desvenlafaxine succinate sustained-release 50 mg/day
    • +2 more
    • Phoenix, Arizona
    • +60 more
    Dec 17, 2013

    MDD Trial in United States (Aripiprazole+ ADT, Placebo+ ADT)

    Completed
    • Major Depressive Disorder
    • Aripiprazole+ ADT
    • Placebo+ ADT
    • Birmingham, Alabama
    • +33 more
    Nov 7, 2013

    MDD Trial in United States (Antidepressant + Placebo, Antidepressant + Aripiprazole)

    Completed
    • Major Depressive Disorder
    • Antidepressant + Placebo
    • Antidepressant + Aripiprazole
    • Beverly Hills, California
    • +27 more
    Nov 22, 2013

    MDD Trial in United States (Antidepressant + Placebo, Antidepressant + Aripiprazole)

    Completed
    • Major Depressive Disorder
    • Antidepressant + Placebo
    • Antidepressant + Aripiprazole
    • Garden Grove, California
    • +19 more
    Nov 22, 2013

    MDD Trial in United States (Antidepressant + Aripiprazole)

    Completed
    • Major Depressive Disorder
    • Antidepressant + Aripiprazole
    • Mesa, Arizona
    • +57 more
    Nov 7, 2013

    MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

    Completed
    • Major Depressive Disorder
    • Levomilnacipran ER
    • Placebo
    • Birmingham, Alabama
    • +50 more
    Aug 22, 2013

    MDD Trial in United States (Levomilnacipran ER, Placebo)

    Completed
    • Major Depressive Disorder
    • Levomilnacipran ER
    • Placebo
    • Phoenix, Arizona
    • +37 more
    Aug 22, 2013

    MDD Trial in United States (Levomilnacipran ER, Placebo)

    Completed
    • Major Depressive Disorder
    • Levomilnacipran ER
    • Placebo
    • Scottsdale, Arizona
    • +24 more
    Aug 22, 2013

    MDD Trial in United States (ABT-436, Escitalopram, Placebo)

    Terminated
    • Major Depressive Disorder
    • Little Rock, Arkansas
    • +17 more
    Oct 4, 2013

    MDD Trial in Worldwide (TC-5214, Duloxetine, Placebo)

    Terminated
    • Major Depressive Disorder
    • Beverly Hills, California
    • +66 more
    Nov 14, 2012

    MDD Trial in United States (AZD2066, Placebo, Duloxetine)

    Terminated
    • Major Depressive Disorder
    • Garden Grove, California
    • +12 more
    Sep 27, 2012

    MDD Trial in United States (F2695 SR)

    Completed
    • Major Depressive Disorder
    • F2695 SR
    • Dothan, Alabama
    • +67 more
    Aug 15, 2012